Endoscopic findings and outcomes of gastric mucosal changes relating to potassium‐competitive acid blocker and proton pump inhibitor therapy

Abstract Gastric mucosal changes associated with long‐term potassium‐competitive acid blocker and proton pump inhibitor (PPI) therapy may raise concern. In contrast to that for PPIs, the evidence concerning the safety of long‐term potassium‐competitive acid blocker use is scant. Vonoprazan (VPZ) is...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Satoshi Shinozaki, Hiroyuki Osawa, Yoshimasa Miura, Hiroaki Nomoto, Hirotsugu Sakamoto, Yoshikazu Hayashi, Tomonori Yano, Edward J. Despott, Hironori Yamamoto
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-04-01
coleção:	DEN Open
Assuntos:	endoscopy gastroesophageal reflux disease potassium‐competitive acid blocker proton pump inhibitor vonoprazan
Acesso em linha:	https://doi.org/10.1002/deo2.400
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!